These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7680146)

  • 1. Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine.
    Fung J; Todo S; Abu-Elmagd K; Jain A; Tzakis A; Martin M; Selby R; Bronsther O; Doyle H; Gayowski T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1130. PubMed ID: 7680146
    [No Abstract]   [Full Text] [Related]  

  • 2. The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A.
    Mueller AR; Platz KP; Blumhardt G; Bechstein WO; Steinmüller T; Christe W; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1995 Feb; 27(1):1117-20. PubMed ID: 7533359
    [No Abstract]   [Full Text] [Related]  

  • 3. Rejection: FK 506 for rescue or maintenance.
    Klintmalm GB; Gibbs JF; McMillan R; Backman L; Levy M; Goldstein RM; Husberg BS; Holman MJ; Gonwa TA
    Transplant Proc; 1993 Apr; 25(2):1914-5. PubMed ID: 7682356
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].
    Arnold JC; Theilmann L
    Z Gastroenterol; 1995 Oct; 33(10):624-5. PubMed ID: 7502559
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.
    Fung J; Abu-Elmagd K; Jain A; Gordon R; Tzakis A; Todo S; Takaya S; Alessiani M; Demetris A; Bronster O
    Transplant Proc; 1991 Dec; 23(6):2977-83. PubMed ID: 1721333
    [No Abstract]   [Full Text] [Related]  

  • 6. Distinct intragraft cytokine gene expression patterns during acute hepatic rejection under cyclosporine versus FK 506 primary immunosuppression.
    Gaweco AS; Otto G; Otto HF; Geisse T; Hofmann WJ
    Transplant Proc; 1994 Dec; 26(6):3111-3. PubMed ID: 7527948
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
    Woodle ES; So S; Jendrisak MD; Perdrizet GA; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1988-9. PubMed ID: 7682358
    [No Abstract]   [Full Text] [Related]  

  • 8. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival.
    Jacob DA; Neumann UP; Bahra M; Langrehr JM; Neuhaus P
    Transplant Proc; 2005 May; 37(4):1691-2. PubMed ID: 15919432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compassionate use of FK 506 in liver transplantation.
    Murio JE; Balsells J; Lázaro JL; Charco R; Margarit C
    Transplant Proc; 1995 Aug; 27(4):2336. PubMed ID: 7544501
    [No Abstract]   [Full Text] [Related]  

  • 11. The spectrum of aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression.
    Torre-Cisneros J; Mañez R; Kusne S; Alessiani M; Martin M; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3040-1. PubMed ID: 1721353
    [No Abstract]   [Full Text] [Related]  

  • 12. FK 506 rescue therapy: early conversion improves efficacy.
    Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1990-1. PubMed ID: 7682359
    [No Abstract]   [Full Text] [Related]  

  • 13. FK 506 versus cyclosporine in pediatric liver transplantation.
    Tzakis AG; Reyes J; Todo S; Green M; Ohya T; Jain A; Abu-Elmagd K; Alessiani M; Fung JJ; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3010-5. PubMed ID: 1721343
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical use of FK 506 in liver transplantation.
    Klintmalm GB
    Transplant Proc; 1996 Apr; 28(2):974-6. PubMed ID: 8623484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease.
    Mueller AR; Platz KP; Bechstein WO; Blumhardt G; Lobeck H; Hop U; Neuhaus P
    Transplant Proc; 1994 Dec; 26(6):3637-9. PubMed ID: 7527984
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurotoxicity of FK 506 in liver transplant recipients.
    Frank B; Perdrizet GA; White HM; Marsh JW; Lemann W; Woodle ES
    Transplant Proc; 1993 Apr; 25(2):1887-8. PubMed ID: 7682355
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group.
    Bismuth H
    Transplant Proc; 1995 Feb; 27(1):45-9. PubMed ID: 7533415
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):635-7. PubMed ID: 7679826
    [No Abstract]   [Full Text] [Related]  

  • 19. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common and sequential overexpression patterns of T-helper cytokines during acute (cellular) rejection, and correlation of proinflammatory cytokine expression with chronic (ductopenic) rejection of human liver allografts: a study under cyclosporine, FK 506, and quadruple BT 563 immunosuppression.
    Gaweco AS; Otto G; Otto HF; Meuer S; Geisse T; Hofmann WJ
    Transplant Proc; 1995 Feb; 27(1):1152-4. PubMed ID: 7533370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.